VISTAGEN THERAPEUTICS, INC. (VTGN)

Import this data to Google Sheets with:

=jivedata("VTGN","financials")

Full statements spill as a table. For one cell: =jivedata("VTGN","Revenue") or =jivedata("VTGN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

VISTAGEN THERAPEUTICS, INC.

VTGN • CIK 0001411685

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Revenue from Contract with Customer, Including Assessed Tax	$1,064	$486	$1,269	$2,501
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-29,358	$-51,411	$-69,678	$-67,613
Income Tax Expense (Benefit)	$4	$7	$7	$7
Net Income (Loss) Attributable to Parent	$-29,362	$-51,418	$-69,685	$-67,620
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax	—	$5	$-7	$-8
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-29,362	$-51,413	$-69,692	$-67,628
Weighted Average Number of Shares Outstanding, Basic	19,354,500	30,877,029	38,073,926	49,123,435
Research and Development Expense	$20,022	$39,375	$54,974	$54,202
General and Administrative Expense	$14,063	$17,084	$18,421	$17,969
Operating Expenses	$34,085	$56,459	$73,395	$72,171
Operating Income (Loss)	$-33,021	$-55,973	$-72,126	$-69,670
Interest Income (Expense), Nonoperating, Net	$3,351	$4,557	$2,441	$2,049
Other Nonoperating Income	$312	$5	$7	$7

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Cash and Cash Equivalents, at Carrying Value	$119,166	$67,131	$30,789	$16,991
Debt Securities, Available-for-sale, Current	—	$13,351	$14,614	$14,739
Property, Plant and Equipment, Net	$435	$476	$427	$375
Prepaid Expense and Other Assets, Current	$1,432	$1,594	$1,540	$2,580
Operating Lease, Right-of-Use Asset	$1,820	$1,335	$801	$659
Assets, Current	$120,672	$82,076	$46,943	$34,310
Other Assets, Noncurrent	—	$454	$393	$392
Assets	$123,653	$84,341	$48,564	$35,736
Contract with Customer, Liability, Noncurrent	$2,674	$391	$0	$0
Operating Lease, Liability, Noncurrent	$1,570	$948	$249	$63
Liabilities	$9,367	$13,951	$13,044	$11,255
Accounts Payable, Current	$1,547	$653	$1,535	$1,000
Accrued Liabilities, Current	$2,235	$8,810	$8,755	$9,238
Notes Payable	—	—	$96	$96
Contract with Customer, Liability, Current	$791	$2,588	$1,710	$234
Operating Lease, Liability, Current	$550	$561	$699	$720
Liabilities, Current	$5,123	$12,612	$12,795	$11,192
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$27	$29	$40	$44
Additional Paid in Capital	$474,441	$481,956	$516,767	$518,759
Treasury Stock, Common, Value	$3,968	$3,968	$3,968	$3,968
Accumulated Other Comprehensive Income (Loss), Net of Tax	—	$5	$-2	$-7
Retained Earnings (Accumulated Deficit)	$-356,214	$-407,632	$-477,317	$-490,347
Stockholders' Equity Attributable to Parent	$114,286	$70,390	$35,520	$24,481
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Outstanding	0	0	0	0
Common Stock, Shares Authorized	325,000,000	325,000,000	325,000,000	325,000,000
Common Stock, Shares, Issued	27,029,731	29,001,481	39,624,839	44,381,433
Treasury Stock, Common, Shares	4,522	4,522	4,522	4,522

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$102,528	$-52,035	$-36,342	$-31,994
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$119,166	$67,131	$30,789	$-1,205
Net Income (Loss) Attributable to Parent	$-29,362	$-51,418	$-69,685	$-67,620
Depreciation, Depletion and Amortization	$127	$150	$199	$211
Gain (Loss) on Disposition of Property Plant Equipment	$-6	$0	$0	$0
Share-based Payment Arrangement, Noncash Expense	$2,182	$4,315	$3,997	$4,072
Operating Lease, Right-of-Use Asset, Amortization Expense	$441	$485	$534	$550
Proceeds from Sale and Maturity of Marketable Securities	—	$12,027	$21,575	$19,175
Payments to Acquire Debt Securities, Available-for-sale	—	$24,984	$22,301	$19,178
Net Cash Provided by (Used in) Investing Activities	$-61	$-13,148	$-877	$-89
Proceeds from Issuance or Sale of Equity	$93,453	$0	$8	$8
Proceeds from Notes Payable	—	—	$1,020	$0
Repayments of Notes Payable	$985	$0	$925	$931
Net Cash Provided by (Used in) Financing Activities	$128,402	$3,210	$30,971	$30,392
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	—	$33	$27
Increase (Decrease) in Prepaid Expense and Other Assets	$-250	$88	$-36	$-917
Increase (Decrease) in Other Operating Assets	—	$-190	$46	$9
IncreaseDecreaseInOperatingLeaseLiability	$-495	$-611	$-561	$-640
Increase (Decrease) in Contract with Customer, Liability	$516	$-412	$-1,195	$-2,427
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$522	$5,681	$828	$3,199
Net Cash Provided by (Used in) Operating Activities	$-25,813	$-42,097	$-66,436	$-62,297

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("VTGN","financials")

Full statements spill as a table. For one cell: =jivedata("VTGN","Revenue") or =jivedata("VTGN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.